David C. U Prichard, William Fletcher, George Barrett, William Marth, Amir Elstein, Marvin Samson, Suzanne Nora Johnson, David Ketsdever, Pamela Joy Barton, Joseph Shaw, Carl Goldfischer, Terry Spraker, Donald Harrison | GenomeWeb

David C. U’Prichard, venture partner of Apax Partners, president of Druid Consulting, and a member of the board of directors of Invitrogen, was recently elected to the board of directors of Ben Franklin Technology. He will serve through January 2006, the group said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.